Olema Pharmaceuticals Inc at Jefferies Healthcare Conference Transcript
Welcome to another great afternoon session here at the Jefferies Healthcare Conference. I'm pleased to have with us the CEO of Olema Pharmaceuticals, Sean Bohen, up here with us. Sean, Olema is developing an oral CERAN. If you'd like to get a little more tactical, we'll get into that.
Questions & Answers
But importantly, there's been a lot of developments data recently and upcoming data later this year. So let's talk a little bit about, just from a high level, first is introduction. What -- where are we with OP-1250 today? What do we know about this molecule today?
What do we know about it recently with some recent data that's presented? And what do you think the street is not appreciating about this molecule you have for breast cancer?
Yes, great. Well, with two hours, we'll be sure to be able to cover all of that. Yeah, no.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
